14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:GNCA
Delisted

Genocea Biosciences Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0001
+0 (+0%)
At Close: Apr 19, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 19th Apr 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Genocea Biosciences prices

Date Open High Low Close Volume
Mar 14, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 13, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 10, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 09, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 08, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 07, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 06, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 03, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 02, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 01, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 28, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 27, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 24, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 23, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 22, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 21, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 17, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 16, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 15, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 14, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 13, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 10, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 09, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 08, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Feb 07, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Golden Star

Ticker Date Change Price
BBCA May 03 1.26% $65.44
ADTH May 03 5.56% $3.24
ISTB May 03 0.0425% $47.11
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
INVH May 03 1.72% $34.39
INTU May 03 1.89% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT